myotonic muscular dystrophy treatment

Ads
related to: myotonic muscular dystrophy treatment
FDA-Approved Treatment Option - Duchenne Muscular Dystrophy

www.dmd-treatment.com/hcp
Learn More About Duchenne Muscular Dystrophy (DMD) Treatment Option. View Safety & Prescribing Information For This FDA-Approved Treatment Option.
Register For Updates · Efficacy Data · Safety Profile · Learn More
Types: Dosing & Administration, Efficacy Data, Safety Information
Dosing & Administration
Learn About Dosing &

Administrating This Treatment

How This Treatment Works
Watch The Video To See How

This Treatment Option Works

Resources
Find Resources For Both You

And Your Patients

Request A Representative
Learn More About This

Treatment Option For Your Patients

Efficacy Data
View Clinical Study Data

For This Treatment

Physician Support
Support Resources To Help Get Your

Patients Started
Visit We Speak Duchenne - Duchenne Muscular Dystrophy

www.WeSpeakDuchenne.com
Register Now To Receive Support And Information About Duchenne Muscular Dystrophy. Duchenne Is Complicated. But Understanding It Doesn’t Have To Be. Find Support Here.
Caregiver Information · Increasing Dystrophin · Insights From Caregivers · Duchenne-Opedia
Types: DMD Education, Duchenne-Opedia, Patient Stories, Helpful Materials
DMD Symptoms
What Is DMD?
Insights For Caregivers
DMD Education
Family Support
Patient Stories

Search results

- What Is Muscular Dystrophy?
  Health via Yahoo News· 8 months ago
  Muscular dystrophy (MD) is a genetic disorder that causes muscle weakness that gets worse over time. About 250,000 people in the United States have some...
- Entrada Skyrockets On $250 Million Deal With Vertex In Muscular Dystrophy
  Investor's Business Daily· 1 year ago
  Entrada Therapeutics inked a $250 million deal with Vertex Pharmaceuticals to develop a muscular...
- Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again
  Investor's Business Daily· 3 weeks ago
  Top-notch biotech stock Dyne Therapeutics broke out Monday after the company unveiled promising test...
- Highly Rated Avidity Biosciences Hammered After Side Effect Sidelines Study
  Investor's Business Daily· 2 years ago
  The Food and Drug Administration placed a muscular dystrophy study from highly rated Avidity...
- Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy
  Investor's Business Daily· 3 months ago
  Top-notch biotech stock Avidity Biosciences tumbled Monday despite unveiling "positive" midstage...
- How A First-Ever In Gene Silencing Catapulted Avidity Biosciences Into The Stratosphere
  Investor's Business Daily· 1 year ago
  Avidity Biosciences unveiled "compelling" results from a muscular dystrophy study Wednesday, leading...
- Dyne shares jump on trial data for muscle disease drugs
  BioPharma Dive via Yahoo Finance· 3 weeks ago
  Updated study results for the biotech’s medicines for myotonic dystrophy Type 1 and Duchenne...
- Avidity (RNA) Down on Partial Hold of Myotonic Dystrophy Study
  Zacks via Yahoo Finance· 2 years ago
  Avidity Biosciences (RNA) reports FDA-imposed partial hold on enrolling new patients in its phase...
- Entrada (TRDA) Surges on Collaboration With Vertex for DMI
  Zacks via Yahoo Finance· 1 year ago
  Shares of Entrada Therapeutics, Inc. TRDA rallied 18.51% after the company announced a collaboration...
- Avidity (RNA) Expands Collaboration With BMY, Shares Rise
  Zacks via Yahoo Finance· 6 months ago
  Shares of Avidity Biosciences, Inc. RNA surged 14.9% following the expansion of its global licensing...